newsfilter
← Latest News
PR Newswire·

Rigel Appoints Mark W. Frohlich, M.D. to Board of Directors

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it has appointed Mark W. Frohlich, M.D. to its Board of Directors. Dr. Frohlich is a...